AXGN 241220 15.00C (AXGN241220C15000) Stock Options, News & Quotes

0.79
+0.57+259.09%

15min DelayClose Dec 20 16:00 ET

0.87High0.41Low

SymbolStock Name

PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Jsmooth420365

Sep 6 07:55

$AxoGen (AXGN.US)$ like it over 13.50

Cantor Fitzgerald sees AVITA's superior growth and high gross margins as reasons for a premium. The firm also sees potential in Pacific Biosciences and AxoGen, and expects positive share price appreciation for Exagen and NeuroPace. A significant catalyst for Nyxoah's stock is anticipated with upcoming DREAM study data.

Cantor Picks RCEL as Best 2024 Medtech Idea; Bullish on PACB, AXGN, CERS

Moomoo AI

Jan 7 09:21

AxoGen's EBIT loss and debt levels could strain its balance sheet despite its US$368.0m market cap. While revenue is growing, its financial performance is considered slow.

Does AxoGen (NASDAQ:AXGN) Have A Healthy Balance Sheet?

Moomoo AI

Dec 26, 2023 19:36

CEO of Axogen, Karen Zaderej is excited for Kathy Weiler to use her vast commercial knowledge to aid the company's goal of becoming cash flow positive. Weiler herself is equally fired up to be able to aid in Axogen's commercial success.

Press Release: Axogen, Inc. Appoints Kathy Weiler to Its Board of Directors